On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.
Hepatic & GI

Hereditary pancreatitis

This inherited disorder primarily affects the pancreas, leading to inflammation and damage. It typically manifests with severe abdominal pain and digestive issues, affecting individuals from childhood or early adulthood.

Autosomal recessive Hepatic & GI OMIM:167800
Rare
Prevalence
Population estimate
25%
Inheritance
Autosomal recessive - chance of passing to each child
2
Associated genes
PRSS1, SPINK1

Overview

Hereditary pancreatitis is a rare inherited condition that causes repeated bouts of acute pancreatitis, where the pancreas becomes suddenly inflamed. Over time, these recurring episodes can lead to chronic pancreatitis, a long-term condition characterised by permanent damage and impaired function of the pancreas [PMID:33671239]. The pancreas is a gland located behind the stomach that plays a crucial role in digestion and blood sugar regulation.

Individuals with hereditary pancreatitis often experience their first attack in childhood or early adulthood. The severity and frequency of these attacks can vary significantly among affected individuals. Unlike other forms of pancreatitis caused by factors such as gallstones or alcohol consumption, hereditary pancreatitis results from specific genetic changes. Hereditary pancreatitis is considered a rare condition.

Symptoms & clinical features

The main symptom of hereditary pancreatitis is abdominal pain, which can be severe and is typically located in the upper abdomen, often radiating to the back. This pain may be accompanied by nausea, vomiting, and fever during acute attacks [PMID:25081198].

As the condition progresses to chronic pancreatitis, additional symptoms can develop. These may include persistent or recurring abdominal pain, weight loss, and problems with digestion due to the pancreas not producing enough digestive enzymes. This digestive insufficiency can lead to fatty stools (steatorrhoea) and malabsorption of nutrients. In some cases, damage to the pancreas can also affect its ability to produce insulin, potentially leading to diabetes.

Video: Genetics 101

Affected organs

The primary organ affected in hereditary pancreatitis is the pancreas. This gland has two main functions: producing digestive enzymes (exocrine function) and hormones like insulin (endocrine function). Repeated inflammation can damage the cells responsible for these functions.

Over time, chronic inflammation can lead to fibrosis (scarring) and calcification (hardening) of the pancreas. This damage can impair both the exocrine function, leading to maldigestion, and the endocrine function, potentially resulting in diabetes. While the pancreas is the directly affected organ, the resulting digestive issues and pain can have wider impacts on general health and quality of life.

Liver
Liver
Hepatic involvement
Cellular impact
Cellular impact
Mechanism at cellular level

Risks & severity

The severity of hereditary pancreatitis can vary. Some individuals may experience infrequent acute attacks, while others suffer from frequent and severe episodes that significantly impact their daily lives. The condition often progresses from acute to chronic pancreatitis, leading to permanent pancreatic damage [PMID:25081198].

Long-standing chronic pancreatitis may be associated with an elevated risk of certain complications, and regular medical surveillance is essential. The age at which symptoms begin varies, but typically occurs in childhood or early adulthood [PMID:33671239].

Genetic causes

Hereditary pancreatitis is primarily caused by changes in PRSS1. This gene encodes cationic trypsinogen, a digestive enzyme synthesised in the pancreas. Under normal circumstances, trypsinogen remains dormant until it enters the small intestine, where conversion to active trypsin occurs. When PRSS1 carries pathogenic variants, trypsinogen may activate prematurely inside the pancreas, triggering self-digestion of pancreatic tissue and resulting inflammation.

Variants in SPINK1 are also linked to hereditary pancreatitis, though less commonly. This gene encodes pancreatic secretory trypsin inhibitor, a protective protein that blocks trypsin activity. When SPINK1 is altered, the inhibitor's protective capacity diminishes, leaving pancreatic tissue vulnerable to damage from inappropriately activated trypsin [PMID:25081198]. Both genetic alterations disrupt the normal control mechanisms that prevent digestive enzyme activation within the pancreas.

  • PRSS1
    serine protease 1
  • SPINK1
    serine peptidase inhibitor Kazal type 1

Inheritance pattern

Hereditary pancreatitis caused by PRSS1 variants typically follows an autosomal dominant inheritance pattern. This means that inheriting one altered copy of the gene from either parent is sufficient to cause the condition. If a parent has hereditary pancreatitis due to a PRSS1 variant, each child has a 1 in 2 (50%) chance of inheriting the genetic change and developing the condition.

Variants in SPINK1 may act as genetic risk factors or modifiers rather than sole causes. The inheritance pattern can vary depending on which gene is involved and the specific family context. Genetic counselling is important for understanding the specific inheritance risks based on the identified genetic cause in a family.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Diagnosis & testing

Diagnosis of hereditary pancreatitis often begins with a clinical suspicion based on recurrent episodes of pancreatitis, especially if there is a family history or if other common causes of pancreatitis have been ruled out. Blood tests may show elevated pancreatic enzyme levels (amylase and lipase) during acute attacks. Imaging studies like ultrasound, CT scans, or MRI may reveal inflammation, damage, or structural changes in the pancreas.

Genetic testing is crucial for confirming a diagnosis of hereditary pancreatitis and identifying the specific genetic changes responsible. This typically involves analysing genes such as PRSS1 and SPINK1. Referrals for genetic testing in the UK are usually made by a gastroenterologist or a clinical geneticist, often via the NHS Genomic Medicine Service, under relevant R-codes (eligibility codes) for rare gastrointestinal conditions in the National Genomic Test Directory. A genetic counsellor can provide support and information regarding testing and its implications.

Management & lifestyle

Management of hereditary pancreatitis focuses on managing acute attacks, preventing further pancreatic damage, and monitoring for complications. During acute episodes, treatment typically involves pain management, intravenous fluids, and bowel rest. For chronic pancreatitis, management strategies include pancreatic enzyme replacement therapy to aid digestion, dietary modifications, and pain relief. Some individuals may require insulin if diabetes develops.

Regular surveillance is important as part of ongoing care. This may involve periodic imaging studies. In some cases, surgical interventions, such as removal of part of the pancreas, may be considered to manage severe pain or other complications. Patients are typically managed through a multidisciplinary team involving gastroenterologists, pain specialists, dietitians, and genetic counsellors as part of the NHS care pathway.

UK care pathway

In the UK, individuals suspected of having a genetic condition like hereditary pancreatitis can be referred through their GP or specialist to NHS Clinical Genetics services. These services provide expert assessment, genetic counselling, and access to genomic testing through the NHS Genomic Medicine Service. Testing for hereditary pancreatitis genes (such as PRSS1 and SPINK1) would fall under relevant R-codes in the NHS National Genomic Test Directory. Genetic counsellors play a key role in explaining inheritance patterns, testing options, and potential implications for patients and their families.

Frequently asked questions

What is the difference between acute and chronic pancreatitis?

Acute pancreatitis is a sudden, short-term inflammation of the pancreas that can cause severe pain. Chronic pancreatitis is a long-term condition where the pancreas becomes permanently damaged and scarred, leading to ongoing digestive problems and pain. Hereditary pancreatitis often starts with acute attacks that can progress to chronic forms.

Can hereditary pancreatitis be cured?

Currently, there is no cure for hereditary pancreatitis. Management focuses on treating symptoms, preventing acute attacks, and managing complications. This involves medication, dietary changes, and sometimes surgery, aiming to improve quality of life and reduce disease progression.

What are the risks for my children if I have hereditary pancreatitis?

If you have hereditary pancreatitis caused by a PRSS1 variant, each child has a 1 in 2 (50%) chance of inheriting the genetic change. The inheritance pattern can vary depending on which gene is involved, so genetic counselling is important for personalised risk assessment tailored to your family's particular genetic cause.

Is a special diet needed for hereditary pancreatitis?

Dietary recommendations for hereditary pancreatitis often include a low-fat diet to reduce the burden on the pancreas. If the pancreas is not producing enough digestive enzymes, enzyme replacement therapy may be prescribed to help with nutrient absorption. A dietitian can provide personalised advice and support.

How is hereditary pancreatitis monitored over time?

Ongoing monitoring typically involves regular clinical assessments and periodic imaging studies to check for changes in the pancreas. Blood tests may monitor pancreatic function and check for diabetes. Your healthcare team will tailor the surveillance schedule based on your individual circumstances and symptoms.

References

  1. Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nature reviews. Gastroenterology & hepatology. 2021. PMID: 34002083
  2. Adam MP, Bick S, Mirzaa GM. PRSS1-Related Hereditary Pancreatitis. 1993. PMID: 22379635
  3. Mayerle J, Sendler M, Hegyi E. Genetics, Cell Biology, and Pathophysiology of Pancreatitis. Gastroenterology. 2019. PMID: 30660731
  4. Mohamed G, Munir M, Rai A. Pancreatic Cancer: Screening and Early Detection. Gastroenterology clinics of North America. 2025. PMID: 39880528
  5. Rieder H, Bartsch DK. Familial pancreatic cancer. Familial cancer. 2004. PMID: 15131409
  6. Adam MP, Bick S, Mirzaa GM. Pancreatitis Overview. 1993. PMID: 24624459
  7. Charnley RM. Hereditary pancreatitis. World journal of gastroenterology. 2003. PMID: 12508340
  8. Das KK, Early D. Pancreatic Cancer Screening. Current treatment options in gastroenterology. 2017. PMID: 28879469
⚠ Draft content. This page has been flagged for manual clinical review and may contain gaps or inaccuracies.
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor.